NDC 55111-130 – Ranitidine Hydrochloride
Ranitidine Hydrochloride 300 mg/1 · Capsule · Oral
Product NDC55111-130
Product details
- Brand name
- Ranitidine Hydrochloride
- Generic name
- Ranitidine Hydrochloride
- Labeler
- Dr. Reddy's Laboratories Limited
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA075742
- Marketed since
- April 1, 2001
- Listing expires
- December 31, 2026
- Pharmacologic class
- Histamine-2 Receptor Antagonist
Active ingredients
- Ranitidine Hydrochloride 300 mg/1
Uses, dosage, side effects and warnings for Ranitidine Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 55111-130-01 | 100 CAPSULE in 1 BOTTLE (55111-130-01) | Apr 1, 2001 |
| 55111-130-30 | 30 CAPSULE in 1 BOTTLE (55111-130-30) | Apr 1, 2001 |
Recalls mentioning this NDC
- D-0168-2020 Nov 13, 2019 · Class II
CGMP Deviations: Presence of NDMA impurity detected in product. - D-0180-2020 Nov 13, 2019 · Class II
CGMP Deviations: Presence of NDMA impurity detected in product.
Other Ranitidine Hydrochloride products
- 55111-129 Ranitidine Hydrochloride 150 mg/1 · Capsule · Dr. Reddy's Laboratories Limited